REPHINE
LIVE

Serial Number

79354991

Owner

Rephine Limited

Attorney

Michael J. Brown

Filing Date

Jun 7, 2022

Add to watchlist:

No watchlists yet
View on USPTO

REPHINE Trademark

Serial Number: 79354991 • Registration: 7369558

REPHINE is a trademark filed by Rephine Limited on June 7, 2022. The trademark is classified under Class 42 (Computer & Scientific), Class 45 (Legal & Security Services). The application is currently registered and active.

Owner Contact Info

Rephine Limited (3 trademarks)

Unit 15a Meadway Court,

Entity Type: 99

Trademark Details

Filing Date

June 7, 2022

Registration Date

April 30, 2024

Published for Opposition

February 13, 2024

Goods & Services

Regulatory compliance auditing; legal compliance auditing; good manufacturing practices audit in the nature of legal compliance auditing; advisory services relating to regulatory affairs in the field of the manufacture of pharmaceuticals; reviewing standards and practices to assure compliance with manufacturing process safety, product safety and product packaging laws and regulations; legal and regulatory information services relating to pharmaceutical manufacturing standards; analysis of data, policy and process, and provision of advice and assistance relating to standards and practices to ensure compliance with manufacturing process safety, product safety and product packaging laws and regulations; legal and regulatory compliance consulting services in the field of the manufacture of pharmaceuticals; legal and regulatory advisory and consultancy services in relation to clinical trials; provision of information and advice relating to regulatory compliance systems in the field of the manufacture of pharmaceuticals; legal services, namely, legal risk assessment services for the security of goods and individuals; project management consulting services relating to regulatory compliance requirements for pharmaceutical manufacturing safety and security; regulatory compliance consulting in the field of the manufacture of pharmaceuticals, namely, provision of benchmarking and reference information relating to pharmaceutical safety standards; information, advisory and consultancy services in relation to the aforesaid

Pharmaceutical product evaluation; quality audits in the nature of product quality evaluation; product quality control testing; product safety testing services; testing services in the field of manufacturing safety; quality assurance consultancy in the field of pharmaceuticals and the manufacture of pharmaceuticals; inspection services of pharmaceuticals and manufacturing processes for pharmaceuticals for quality control; inspection of manufacturing processes to determine conformance with certification standards for quality, reliability, and safety; inspection of pharmaceuticals; product quality testing services; testing of pharmaceuticals; quality control for others to determine conformance with established product certification standards; product quality evaluation services in the nature of quality control for others; industrial analysis services in the field of pharmaceuticals and manufacturing processes for pharmaceuticals; testing, inspection, quality control, evaluation, verification and analysis of medical products and pharmaceuticals for others; testing, inspection, quality control, verification, evaluation and analysis of medical products and pharmaceuticals for others for compliance with quality standards; testing, quality control inspection, evaluation, verification and analysis of quality management systems, manufacturing systems, manufacturing methods and manufacturing processes; conducting clinical trials for others; scientific research in the nature of scientific study protocol development; research and development in the pharmaceutical field; information, advisory and consultancy services in relation to the aforesaid

Filing History

NEW REPRESENTATIVE AT IB RECEIVED
May 14, 2026 NREP
FINAL DECISION TRANSACTION PROCESSED BY IB
Nov 17, 2024 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Oct 26, 2024 FICS
FINAL DISPOSITION PROCESSED
Oct 26, 2024 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jul 30, 2024 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Apr 30, 2024 NRCC
REGISTERED-PRINCIPAL REGISTER
Apr 30, 2024 R.PR
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Apr 29, 2024 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Apr 10, 2024 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Apr 10, 2024 OPNR
NOTIFICATION PROCESSED BY IB
Feb 14, 2024 GPNX
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Feb 13, 2024 NPUB
PUBLISHED FOR OPPOSITION
Feb 13, 2024 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jan 24, 2024 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Jan 24, 2024 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jan 24, 2024 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Jan 10, 2024 PREV
ASSIGNED TO LIE
Jan 10, 2024 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 22, 2023 CNSA
EXAMINER'S AMENDMENT ENTERED
Nov 22, 2023 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Nov 22, 2023 GNEN
EXAMINERS AMENDMENT E-MAILED
Nov 22, 2023 GNEA
EXAMINERS AMENDMENT -WRITTEN
Nov 22, 2023 CNEA
PREVIOUS ALLOWANCE COUNT WITHDRAWN
Nov 14, 2023 ZZZX
WITHDRAWN FROM PUB - OG REVIEW QUERY
Oct 3, 2023 PBCR
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 18, 2023 CNSA
EXAMINER'S AMENDMENT ENTERED
Sep 14, 2023 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Sep 14, 2023 GNEN
EXAMINERS AMENDMENT E-MAILED
Sep 14, 2023 GNEA
EXAMINERS AMENDMENT -WRITTEN
Sep 14, 2023 CNEA
EXAMINER'S AMENDMENT ENTERED
Jul 17, 2023 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jul 17, 2023 GNEN
EXAMINERS AMENDMENT E-MAILED
Jul 17, 2023 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jul 17, 2023 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 21, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 20, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 20, 2023 TROA
REFUSAL PROCESSED BY IB
Jun 18, 2023 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jun 1, 2023 RFCS
REFUSAL PROCESSED BY MPU
Jun 1, 2023 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Apr 4, 2023 RFCR
NON-FINAL ACTION WRITTEN
Apr 3, 2023 CNRT
ASSIGNED TO EXAMINER
Mar 22, 2023 DOCK
APPLICATION FILING RECEIPT MAILED
Nov 18, 2022 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 14, 2022 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Nov 10, 2022 REPR